Catalyst Wire Dossier Catalyst Wire Dossier

Recombinant Modified Vaccinia Virus Ankara (MVA) HIV vaccine

Modified Vaccinia Virus Ankara-based HIV vaccine · Bavarian Nordic
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Recombinant Modified Vaccinia Virus Ankara (MVA) HIV vaccine, covering 2015-01-27 to 2015-01-27. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Immunogenicity Study of Recombinant Modified Vaccinia Virus Ankara (MVA) Virus to Treat HIV Infection [Phase 1]

See pricing